(6aS)-2-(Hexan-2-yloxy)-1,9,10-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H,dibenzo[de,g]quinoline

ID: ALA5175973

Chembl Id: CHEMBL5175973

PubChem CID: 168277348

Max Phase: Preclinical

Molecular Formula: C26H35NO4

Molecular Weight: 425.57

Names and Identifiers

Canonical SMILES:  CCCCC(C)Oc1cc2c3c(c1OC)-c1cc(OC)c(OC)cc1C[C@@H]3N(C)CC2

Standard InChI:  InChI=1S/C26H35NO4/c1-7-8-9-16(2)31-23-13-17-10-11-27(3)20-12-18-14-21(28-4)22(29-5)15-19(18)25(24(17)20)26(23)30-6/h13-16,20H,7-12H2,1-6H3/t16?,20-/m0/s1

Standard InChI Key:  VWVIQARDKDWUEK-FZCLLLDFSA-N

Alternative Forms

1. Parent:

   

   ALA5175973

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 425.57

Molecular Weight (Monoisotopic): 425.2566

AlogP: 5.42

#Rotatable Bonds: 8

Polar Surface Area: 40.16

Molecular Species: NEUTRAL

HBA: 5

HBD: ┄

#RO5 Violations: 1

HBA (Lipinski): 5

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 7.01

CX LogP: 5.26

CX LogD: 5.11

Aromatic Rings: 2

Heavy Atoms: 31

QED Weighted: 0.56

Np Likeness Score: 1.08

References

1. Namballa HK, Madapa S, Sigalapalli DK, Harding WW..  (2022)  Semisynthetic Transformations on (+)-Boldine Reveal a 5-HT_2A/2CR Antagonist.,  85  (9.0): [PMID:36001775] [10.1021/acs.jnatprod.2c00365]

Source

Source(1):

• Scientific Literature